Home
Cannapedia Encyclopedia of cannabis strains

Primary tabs

Seedbank
DNA Genetics

Holy Grail

Average rating: 4.2 (15× ratings)
Feminized
Hybrid
Indoor

Drum Roll Please…We now introduce THE HOLY GRAIL KUSH!! All of us growers have been searching for the one plant, if you had to pick only one, to have with you on a deserted island... Well the search can be temporarily suspended. DNA presents the cannabis community with the 2 time Cannabis Cup Champion, Kosher Kush, crossed with the Multi-Champion strain, The OG #18, bringing you... The Holy Grail Kush! This cross produces large resinous buds that reak of OG #18/Kosher goodness!! New, or fairly new, carbon filters are highly recommended as the smell can be over powering! The Holy Grail is great for the beginner as well as the Master grower. The experienced growers can take her to the limit, pushing the nutrient uptake to the very edge and being rewarded with insanely aromatic plants with the strength and yield not to be matched! The Holy Grail will demand the highest price of all the OG Kush hybrids. Several High Times staff were heard talking of how superior the Holy Grail Kush was in looks, smell and taste. Far out performing ALL other entries in 2011 HTCC to take First place with a first ever perfect score!! Now the world can try The Holy Grail Kush! 1st Hybrid HT Cannabis Cup 2011 2nd Indoor Hydro Spannabis 2012.

Fundamental parameters

Information about the origin and the life cycles of plants

Type
mostly indica
Indoor flowering time
9 weeks
Genetics
Kosher Kush x The OG #18
Breeder
DNA Genetic
Country
Netherlands

Indication

What difficulties can help this variety

Chronic Pain
Tinnitus
Anorexia Nervosa
Migraine
Anxiety
Upset stomach

Effects

As this variety will be affect on you

Headaches
Euphoria
Relaxing
Dry eyes
Dry mouth
Vertigo

Sellers

Where to buy seeds

DNA Genetics
Sint Nicolaasstraat 41, Amsterdam, 1012 NJ,
Buy Now

Diskuze

Add comment
Brianna (not verified)
9 years 8 months
I came here to work esssay The ASTERIA I study showed that patients treated with omalizumab 300 mg dose responded as early as Week 1, compared to Week 4 in the placebo group. By Week 12, all three omalizumab doses of 300 mg, 150 mg and 75 mg were significantly superior to placebo in improving patients' weekly Itch Severity Score or ISS, which was the primary endpoint of the study. This benefit was maintained throughout active treatment.
5158
Ellis (not verified)
9 years 8 months
When can you start? i can do my assignment The study of over 55s by Key Retirement Solutions found just under three per cent of grandparents have already helped with fees, but this is predicted to increase to 13 per cent in the next ten years.
5158

In the database, there are no reviews. Be the first one is reviewing this product!